0001104659-20-105255.txt : 20200915 0001104659-20-105255.hdr.sgml : 20200915 20200915163041 ACCESSION NUMBER: 0001104659-20-105255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200914 FILED AS OF DATE: 20200915 DATE AS OF CHANGE: 20200915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Barbara Gayle CENTRAL INDEX KEY: 0001353128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 201176303 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 a4.xml 4 X0306 4 2020-09-14 0 0000722830 IMMUNOMEDICS INC IMMU 0001353128 Duncan Barbara Gayle 62 LAKESHORE DRIVE EASTCHESTER NY 10709 1 0 0 0 Common Stock, $0.01 par value per share 2020-09-14 4 M 0 2500 16.96 A 39577 D Common Stock, $0.01 par value per share 13385 D Stock Option (right to buy) 16.96 2020-09-14 4 M 0 2500 0 D 2020-03-05 2026-03-05 Common Stock, par value $0.01 per share 2500 0 D Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. /s/ Barbara Duncan 2020-09-15